Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01265212 · ClinicalTrials.gov registry record

Prevalence of Human Papillomavirus in Men Living in the Northern Plains

A clinical trial, sponsored by Sanford Health.

Completed
Registry status
110
Enrollment target

NCT01265212: Completed study, sponsored by Sanford Health.

NCT01265212 is a clinical trial that has completed, run by Sanford Health. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01265212 has completed, sponsored by Sanford Health.

COMPLETED
Registry status
110 participants
Enrollment target

Study Summary

HPV infection is associated with cervical and other anogenital cancers. HPV may also be associated with the development of prostate cancer. The purpose of the study is to determine the prevalence of HPV infection in men living in South Dakota.

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2010-09
Est. Completion 2013-10
Sanford Health

34 total trials

What the finished NCT01265212 record still lists

NCT01265212 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01265212 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01265212 about?

NCT01265212 is a clinical study titled "Prevalence of Human Papillomavirus in Men Living in the Northern Plains". HPV infection is associated with cervical and other anogenital cancers. HPV may also be associated with the development of prostate cancer. The purpose of the study is to determine the prevalence of HPV infection in men living in South Dakota.

What is the current status of trial NCT01265212?

This trial is currently completed. The enrollment target is 110 participants. The study started on 2010-09. Estimated completion is 2013-10.

Who is sponsoring clinical trial NCT01265212?

This trial is sponsored by Sanford Health, which has 34 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01530373 · 110 participants · Phase 2

    Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

  • NCT02379377 · 110 participants · Phase 1

    18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

  • NCT02411773 · 110 participants · Phase 1

    Sympatholysis in Chronic Kidney Disease

  • NCT03190941 · 110 participants · Phase 1

    Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01265212, the US trial registry maintained by the National Library of Medicine. NCT01265212 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.